Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Practice Organization Not Tied to Family Physician […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Continuous PPI Use May Increase Risk for Acute […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Continuous PPI Use May Increase Risk for […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Neurology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for Status […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Nursing for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Antimicrobial Resistance Patterns Examined for Adult, Peds HAIs […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Fewer Interval Cancers Diagnosed With […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Fewer Interval Cancers Diagnosed With Supplemental […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Ophthalmology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Orthopedics for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Pediatrics for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for Status […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Practice Organization Not Tied to Family Physician Burnout […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Pulmonology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Object-Related Aspiration Deaths Decreased Among Children WEDNESDAY, Nov. […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Surgery for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Rates of Postoperative Mortality High for Frail, Very […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Urology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Study Supports PSA Screening for Male BRCA2 Carriers […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Rates of Postoperative Mortality High for Frail, […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Emergency Medicine for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for […]
Read MoreHere are what the editors at HealthDay consider to be the most important developments in Otolaryngology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Object-Related Aspiration Deaths Decreased Among Children WEDNESDAY, Nov. […]
Read More
